Apollo Biotech

RESEARCH USE ONLY: These products are strictly for laboratory research purposes and not for human consumption.

Back to Knowledge Base

CJC-1295

Growth Hormone-Releasing Hormone Analogue

Peptide Profile

Sequence

YADAIFTQSYRKVLAQLSARKLLQDIMSR

Molecular Weight

3367.9 g/mol

Storage Requirements

For maximum stability, store the lyophilized powder at -20°C (or -80°C for long-term preservation) protected from light and moisture. Once reconstituted with bacteriostatic water or sterile saline, the solution should be kept refrigerated at 2°C to 8°C and utilized within 14–21 days. Avoid repeated freeze-thaw cycles and keep vials tightly sealed until use to maintain compound integrity.

Relevant Literature

Recent in-vitro studies:

Selected in-vitro / cell-based PubMed literature relevant to this compound:

  1. Reference 1

    L Jetté et al. (2005). Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Endocrinology. PMID: 15817669.

    View on PubMed
  2. Reference 2

    S Memdouh et al. (2021). Advances in the detection of growth hormone releasing hormone synthetic analogs. Drug Test Anal. PMID: 34665524.

    View on PubMed
  3. Reference 3

    A Knoop et al. (2016). Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS. Drug Test Anal. PMID: 26879649.

    View on PubMed